166 related articles for article (PubMed ID: 10064011)
1. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic.
Kawasaki T; Kaida T; Arnout J; Vermylen J; Hoylaerts MF
Thromb Haemost; 1999 Feb; 81(2):306-11. PubMed ID: 10064011
[TBL] [Abstract][Full Text] [Related]
2. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
3. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
Schwarz HP; Schlokat U; Mitterer A; Váradi K; Gritsch H; Muchitsch EM; Auer W; Pichler L; Dorner F; Turecek PL
Semin Thromb Hemost; 2002 Apr; 28(2):215-26. PubMed ID: 11992244
[TBL] [Abstract][Full Text] [Related]
4. Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.
Turecek PL; Gritsch H; Richter G; Auer W; Pichler L; Schwarz HP
Thromb Haemost; 1997 Mar; 77(3):591-9. PubMed ID: 9066015
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
6. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
Li X; Gabriel DA
Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
[TBL] [Abstract][Full Text] [Related]
7. The factor VIII/von Willebrand factor complex: basic and clinical issues.
Federici AB
Haematologica; 2003 Jun; 88(6):EREP02. PubMed ID: 12826528
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients.
Huser B; Lämmle B; Landmann J; Tran TH; Oberholzer M; Marbet GA; Thiel G; Mihatsch MJ; Duckert F
Clin Nephrol; 1990 Nov; 34(5):214-22. PubMed ID: 2125251
[TBL] [Abstract][Full Text] [Related]
9. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
Deitcher SR; Tuller J; Johnson JA
Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
[TBL] [Abstract][Full Text] [Related]
10. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
Kao KJ; Pizzo SV; McKee PA
J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
Furlan M; Perret BA; Beck EA
Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
[TBL] [Abstract][Full Text] [Related]
12. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin. An animal model.
Sanders WE; Read MS; Reddick RL; Garris JB; Brinkhous KM
Lab Invest; 1988 Oct; 59(4):443-52. PubMed ID: 3262788
[TBL] [Abstract][Full Text] [Related]
14. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
André P; Brouland JP; Roussi J; Bonneau M; Pignaud G; Bal dit Sollier C; Hainaud P; Vaiman M; Drouet L
Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
Behrmann M; Pasi J; Saint-Remy JM; Kotitschke R; Kloft M
Thromb Haemost; 2002 Aug; 88(2):221-9. PubMed ID: 12195693
[TBL] [Abstract][Full Text] [Related]
16. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
Gilles JG; Lavend'homme R; Peerlinck K; Jacquemin MG; Hoylaerts M; Jorieux S; Mazurier C; Vermylen J; Saint-Remy JM
Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452
[TBL] [Abstract][Full Text] [Related]
17. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
Hubbard AR; Rigsby P; Barrowcliffe TW
Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
[TBL] [Abstract][Full Text] [Related]
18. Seminal Factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?
Lwaleed BA; Greenfield R; Royle E; Birch B; Cooper AJ
Int J Androl; 2005 Feb; 28(1):31-8. PubMed ID: 15679619
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
Neugebauer BM; Goy C; Budek I; Seitz R
Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIII and factor VIII-von Willebrand factor complex do not present danger signals for human dendritic cells.
Pfistershammer K; Stöckl J; Siekmann J; Turecek PL; Schwarz HP; Reipert BM
Thromb Haemost; 2006 Sep; 96(3):309-16. PubMed ID: 16953272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
